Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | PTPN7 | P35236 | 4/20 | 0.43 |
| ▸ | HMGCR | P04035 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL879891 | 0.92 | SMN1; SMN2 (0.58) | ALDH1A1SMN1; SMN2LMNATSHRMEN1 | |
| SCHEMBL12680241 | 0.92 | SMN1; SMN2 (0.58) | ALDH1A1SMN1; SMN2LMNATSHRMEN1 | |
| SCHEMBL1330000 | 0.89 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2LMNATSHRMEN1 | |
| SCHEMBL11829814 | 0.89 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2LMNATSHRMEN1 | |
| SCHEMBL25764481 | 0.89 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2LMNATSHRMEN1 | |
| SCHEMBL25564483 | 0.89 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2LMNATSHRMEN1 | |
| SCHEMBL5359169 | 0.89 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2LMNATSHRMEN1 | |
| SCHEMBL562635 | 0.89 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2LMNATSHRMEN1 | |
| SCHEMBL3190238 | 0.89 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2LMNATSHRMEN1 | |
| SCHEMBL487757 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4737436-A1 | CATIONIC LIPID CONTAINING TWO TERTIARY AMINE GROUPS, AND USE THEREOF | Xiamen Sinopeg Biotech Co., Ltd (CN) | 2026-05-06 | — | — | EP | disclosed |
| CN-119562942-A | Cationic lipid containing two tertiary amine groups and application thereof | 厦门赛诺邦格生物科技股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| WO-2025001700-A1 | CATIONIC LIPID CONTAINING TWO TERTIARY AMINE GROUPS, AND USE THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2025-01-02 | — | — | WO | disclosed |
| US-20230310334-A1 | LIPID NANOPARTICLE | Shenzhen Shenxin Biotechnology Co., Ltd. (CN) | 2023-10-05 | — | — | US | disclosed |
| US-20230310334-A1 | LIPID NANOPARTICLE | Shenzhen Shenxin Biotechnology Co., Ltd. (CN) | 2023-10-05 | — | — | US | disclosed |
| EP-4201400-A1 | LIPID NANOPARTICLE | Shenzhen Shenxin Biotechnology Co., Ltd. (CN) | 2023-06-28 | — | — | EP | disclosed |
| CN-114073677-B | Lipid nanoparticle | 深圳深信生物科技有限公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-115867318-A | Lipid nanoparticle | 深圳深信生物科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-114073677-A | Lipid nanoparticle | 深圳深信生物科技有限公司 | 2022-02-22 | — | — | CN | disclosed |
| US-4440940-A | HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1984-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230310334-A1 | LIPID NANOPARTICLE | LCAT, NPC1, CETP | ALDH1A1 989/4885SMN1; SMN2 2132/4885LMNA 1799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.